English, PDF, 1,103kb
This report presents findings and analyses regarding formal status, governance, establishment, funding, access and other issues. It is the result of a survey of existing infrastructures, followed by discussions among infrastructure practitioners: researchers, facility administrators, officials of ministries and funding agencies.
An ageing population brings new challenges both to healthcare systems and to medicine in terms of the increased manifestation of specific diseases primarily seen in the elderly. Biomedical innovation, and in particular research into "omics technologies", offers the promise of new means of detection, prevention and treatment of age-related disabilities and diseases.
This publication addresses the role of national systems of IP in the socio-economic development of emerging countries, notably through their impact on innovation. It presents a framework that identifies the key mechanisms that enable IP systems to support emerging countries’ innovation and development objectives.
The Innovation Policy Platform (IPP) is a one-of-a-kind web-based interactive space that provides easy access to open data, learning resources and opportunities for collective learning on the design, implementation, monitoring and evaluation of locally appropriate innovation policies.
English, PDF, 3,023kb
In very simple terms, smart specialisation suggests that countries or regions should identify and select a limited number of priority areas for knowledge-based investments, focusing on strengths and comparative advantages. This report uses case studies to illustrate how smart specialisation can be used to design better public policies for boosting innovation-driven growth in OECD regions. It also examines governance and evaluation.
This report describes recent trends in government and institutional level policies to enhance the transfer and exploitation of public research. It also benchmarks a set of countries, universities and public research institutions based on both traditional and new indicators.
This report examines examples of new and emerging governance models that aim to support the responsible development of diagnostics and treatments based on the latest advances in biomedicine. In particular, it presents programmes and initiatives that aim to manage uncertainty in the development and approval of new medical products and thereby to improve the understanding of the risk/benefit balance.
This paper presents the findings of a survey of 25 countries. It provides a snapshot of current national or regional policy and research programmes designed to stimulate the growth of nanotechnology applications in diverse sectors of the economy while addressing the potential risks and the ethical and social challenges the technology might raise.
This new document is available as a tool for environmental safety assessment of new varieties of sugarcane derived from modern biotechnology. Given the large production of this crop worldwide, its biosafety will be an important issue for many countries.
The economic and social impact of chronic brain disorders such as Alzheimer’s disease and other neurodegenerative diseases will become the number one public-health problem worldwide, directly affecting 100 million people by 2050.